COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 577: Articles 5761-5770  | Next

A machine learning approach identifies unresolving secondary pneumonia as a contributor to mortality in patients with severe pneumonia, including COVID-19
Gao, C. A., Markov, N. S., Stoeger, T., Pawlowski, A. E., Kang, M., Nannapaneni, P., Grant, R. A., Pickens, C. O., Walter, J. M., Kruser, J. M., Rasmussen, L. V., Schneider, D., Starren, J., Donnelly, H. K., Donayre, A., Luo, Y., Budinger, G. S., Wunderink, R. G., Misharin, A. V., Singer, B. D., NU SCRIPT Study Investigators
10.1101/2022.09.23.22280118 — Posted: 2022-09-25
Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria.
Olawoye, I. B., Oluniyi, P. E., Parker, E., Oguzie, J. U., Uwanibe, J. N., Kayode, T. A., Ajogbasile, F. V., Olumade, T. J., Eromon, P., Abechi, P., Sobajo, T., Ugwu, C., Uwem, G., Ayoade, F., Akano, K., Akinlo, O. O., Akin-John, J. O., Oyejide, N., Ayo-Ale, O., Adegboyega, B., Chukwu, G. C., Adeleke, A., Ezekiel, G. O., Brimmo, F., Fayemi, O. O., Fred-Akintunwa, I., Yusuf, I. F., Ipaye, T. O., John, O., Muhammad, A. I., Nwodo, D. C., Ogunsanya, O. A., Okolie, J., Omoniyi, A. E., Omwanghe, I. B., Ope-ewe, O. O., Otitoola, S., Adedotun-Suleiman, K., Philip, C., Saibu, M. F., Sijuwola, A. E., Terkuma, C. A., Abu, A., Adeniji, J. A., Adewunmi, M. O., Adeyemi, O. O., Ahmed, R., Ahumibe, A., Ajayi, A. N., Akanbi, O., Akande, O., Akinola, M., Akinpelu, A., Akpede, G., Anieno, E., Atage, A. E., Ayansola, O., Baba, M., Babatunde, O., Oderinde, B. S., Benevolence, E., Blessing, O., Bob-Manuel, M., Bock-Oruma, A., Chris, A., Chukwu, C., Daramola, F., Donatus, A., Duruihuoma, R., Edna, Y., Ekeh, M., Ndoma, E., Ewah, R., Fajola, A., Fakayode, E. O., Fowotade, A., Gadzama, G., Igwe, D., Ikponmwosa, O., Isamotu, R. O., Jacqueline, A., John, A., Ekpo, J. J., Kida, I., Mba, N., Micheal, A., Tatfeng, M. Y., Moore-Igwe, W. B., Moses, A., Naregose, O., Ntia, N.-A., Nwafor, I., Odeh, E., Ogbaini, E., Ojide, K. C., Okogbenin, S., Okokhere, P., Okoro, S., Okwuraiwe, A., Olasunkanmi, O., Olayinka, O., Omoare, A., Omoruyi, E. C., Omunakwe, H. E., Ogah, E. O., Onwuamah, C., Onyia, V., Patience, A., Paulson, E., Racheal, O., Rita, E., Rosemary, G., Shaibu, J., Shaibu, J., Solomon, E., Ugwu, N., Ugwu, C. N., Ukwuaja, K., Wudiri, Z., Ndodo, N., Petros, B., Mcannis, B., Oshomah, C., Oladiji, F., Siddle, K. J., Audu, R., Salako, B. L., Schaffner, S., Park, D., Adetifa, I., Ihekweazu, C., Tomori, O., Happi, A. N., Folarin, O., Andersen, K. G., Sabeti, P. C., Happi, C. T.
10.1101/2022.09.24.22280269 — Posted: 2022-09-25
Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management
El-Zein, M., Ali, R., Farah, E., Botting-Provost, S., Franco, E. L., Survey Study Group
10.1101/2022.09.23.22279458 — Posted: 2022-09-25
Impact of COVID-19 on lifestyle and mental wellbeing in a drought-affected rural Australian population: A mixed method approach
Carlson, J., Chan, K., Gray, J., Xue, H., Reed, K., Bailey, J. K., Dutton, T., Osuagwu, U. L., Vines, R.
10.1101/2022.09.23.22280278 — Posted: 2022-09-25
Determinants of self-reported health status during COVID-19 lockdown among surveyed Ecuadorian population: a cross sectional study
Duenas-Espin, I., Jacques- Avino, C., Egas-Reyes, V., Larrea, S., Torres-Castillo, A. L., Trujillo, P., Peralta, A.
10.1101/2022.09.23.22280279 — Posted: 2022-09-25
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, , Horby, P. W., Peto, L., Staplin, N., Campbell, M., Pessoa-Amorim, G., Mafham, M., Emberson, J. R., Stewart, R., Prudon, B., Uriel, A., Green, C. A., Dhasmana, D. J., Malein, F., Majumdar, J., Collini, P., Shurmer, J., Yates, B., Baillie, J. K., Buch, M. H., Day, J. N., Faust, S. N., Jaki, T., Jeffery, K., Juszczak, E., Knight, M., Lim, W. S., Montgomery, A., Mumford, A., Rowan, K., Thwaites, G., Haynes, R., Landray, M.
10.1101/2022.09.23.22280285 — Posted: 2022-09-25
When should healthcare workers with COVID-19 return to work? An analysis of follow-up antigen test results after a positive COVID test
Baffoe-Bonnie, A. W., Swann, M. C., Kim, C. H. S.
10.1101/2022.09.24.22280327 — Posted: 2022-09-25
Development of Q-LAAD, an allonamer-based antigen test for the rapid detection of SARS-CoV-2
Overgaard, E., Li, S., Covert, H. J., Tawara, K., Poe, A. M., Shults, N. H., Chernish, A. A., Sweet, B., Gonzales, C. R., Gibard, C. F., Burden, S. J.
10.1101/2022.09.23.22280297 — Posted: 2022-09-25
Natural ventilation, low CO2 and air filtration are associated with reduced indoor air respiratory pathogens
Raymenants, J., Geenen, C., Budts, L., Thibaut, J., Thijssen, M., De Mulder, H., Gorissen, S., Craessaerts, B., Laenen, L., Beuselinck, K., Ombelet, S., Keyaerts, E., Andre, E.
10.1101/2022.09.23.22280263 — Posted: 2022-09-23
Excess death estimates from multiverse analysis in 2009-2021
Levitt, M., Zonta, F., Ioannidis, J.
10.1101/2022.09.21.22280219 — Posted: 2022-09-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).